Evidence map›Paper›PMID 41992381›Full record

ArticleArchives of public health = Archives belges de sante publique2026

Reasons for HIV testing in women diagnosed with HIV (2000-2023): insights from a 24-year retrospective cohort study in Barcelona, Spain.

Sara Toyos, Leire Berrocal, Ana González-Cordón, Emma Fernández, Alexy Inciarte, Lorena de la Mora, María Martínez-Rebollar, Montserrat Laguno, Juan Ambrosioni, Iván Chivite and 8 more

Abstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sara Toyos *Hospital Sierrallana, Internal Medicine Service, Bo. Ganzo, unnumbered, Torrelavega, 39300, Spain. sara.toyos@outlook.com.
Leire Berrocal *HIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Ana González-CordónHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Emma FernándezHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Alexy InciarteHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Lorena de la MoraHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
María Martínez-RebollarHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Montserrat LagunoHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Juan AmbrosioniHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Iván ChiviteHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Elisa de LazzariHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Alberto FoncillasHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Júlia CalvoHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
José Luis BlancoHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Esteban MartínezHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
José M MiróHIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Josep Mallolas *HIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Berta Torres *HIV Unit, Hospital Clínic Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDetermining the reasons for HIV test performance in women living with HIV (WLWH) is crucial for evaluating areas for improvement in early diagnosis.

methodsThe primary objective of the study was to define the reasons for HIV testing in cisgender WLWH who had their first visit in Hospital Clínic, Barcelona, between January 2000 and December 2023. Reasons were classified into: pregnancy and preconception care, AIDS-defining events (ADE), diagnosis in a sexual partner, indicator condition (IC), patient-initiated testing, physician-initiated testing, and “other”. Secondary objectives included the proportion of late and advanced diagnosis, and analysing viral load (VL), CD4 count, and patient status at 48 weeks. Data were compared between two periods (January 2000 to December 2014 and January 2015 to December 2023).

resultsThe study included 537 women. The main reasons for HIV testing were pregnancy and preconception care (24%) and indicator conditions (22%). Overall, late and advanced diagnoses were observed in 56% and 32% of women, respectively. As expected, women diagnosed following an AIDS defining event presented with the lowest CD4 counts, while those tested due to an indicator condition also showed high proportions of late (66%) and advanced (43%) diagnoses. Spanish women had a lower risk of late diagnosis compared with non-Spanish women, particularly when diagnosed during pregnancy or preconception care, 0.39 (95% CI: 0.18–0.87, p = 0.021). At 48 weeks, CD4 counts remained below 400 cells/mm³ in late-diagnosed women across both periods.

conclusionThese findings underscore the importance of targeted strategies to promote earlier HIV detection and improve long-term health outcomes in women.

Indexed as

Early diagnosisHIVHIV testingPreventionTestWomen

Identifiers

PMID41992381
PMCPMC13214212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.